How cannabinoids suppress the immune system by triggering immune cell death | Research

The takeaway

A review described four pathways through which cannabinoids suppress immunity: cell death (apoptosis), proliferation inhibition, cytokine suppression, and induction of regulatory T cells.

Read this if you want to understand how cannabinoids interact with the immune system and their potential for treating autoimmune conditions.

CB2 receptor targeting could suppress immunity without psychoactive effects

What the researchers found

The review catalogued how cannabinoids mediate immunosuppression through four broad mechanisms:

1. Apoptosis (programmed cell death) of immune cells, primarily through CB2 receptor activation

2. Inhibition of immune cell proliferation

3. Suppression of cytokine and chemokine production

4. Induction of regulatory T cells (Tregs) that dampen immune responses

CB2 receptors, predominantly expressed on immune cells, emerged as the key therapeutic target. The authors noted that cannabinoids had shown beneficial effects in models of multiple sclerosis, diabetes, septic shock, rheumatoid arthritis, and allergic asthma.

Importantly, CB2-targeted therapies could achieve immunosuppression without the psychoactive effects mediated by CB1 receptors in the brain.

Why it matters

The identification of CB2 receptor-targeted immunosuppression offered a pathway to develop anti-inflammatory therapies without the psychoactive effects of cannabis, potentially benefiting patients with autoimmune and inflammatory conditions.

The numbers in context

Four immunosuppressive pathways identified. Beneficial effects demonstrated in models of at least five autoimmune/inflammatory conditions.

How the study worked

Narrative review focusing on mechanisms of cannabinoid-induced apoptosis in immune cells, synthesizing laboratory findings on CB2 receptor-mediated immunosuppression across multiple immune cell types and disease models.

What this study cannot tell us

Primarily based on preclinical and in vitro studies. Translation to human autoimmune disease treatment remained speculative. The immunosuppressive effects could theoretically increase infection susceptibility.

How to read the evidence

Comprehensive mechanistic review synthesizing substantial laboratory evidence on multiple immunosuppressive pathways.

When this study was published

Published in 2010. CB2-targeted drug development for autoimmune conditions has continued.

The bigger picture

This research positioned the cannabinoid system as a potential therapeutic target for autoimmune diseases, with CB2 receptor selectivity offering a way to separate medical benefits from psychoactive effects.

Questions still open

Can CB2-selective drugs effectively treat autoimmune diseases in humans without increasing infection risk? What is the balance between beneficial immunosuppression and harmful immune compromise?

Common questions

Could cannabis help with autoimmune diseases?

Preclinical research showed cannabinoids suppressing immune responses through four mechanisms. CB2-selective drugs showed promise in models of MS, diabetes, arthritis, and asthma, but clinical translation was still early.

Does cannabis weaken the immune system?

Cannabinoids can suppress certain immune responses through multiple mechanisms. This immunosuppression could be harmful (increasing infection risk) or beneficial (treating autoimmune conditions where the immune system attacks the body).

Read the original research

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.

Immunobiology, 215(8), 598-605

View on PubMed ↗Publisher’s paper ↗

Citation

Rieder, Sadiye Amcaoglu; Chauhan, Ashok; Singh, Ugra; Nagarkatti, Mitzi; Nagarkatti, Prakash. (2010). Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.. Immunobiology, 215(8), 598-605. https://doi.org/10.1016/j.imbio.2009.04.001